Background

A decrease in brain temperature (Tbrain) causes a decrease in the cerebral metabolic rate for oxygen (CMRO2) and provides potent neuroprotection against ischemic damage. In the present study, the effects of mild to moderate hypothermia on cerebral tissue oxygen tension (PO2 brain), carbon dioxide tension (PCO2 brain), and pH (pHbrain) were monitored during short episodes of global cerebral ischemia.

Methods

After approval by the Animal Care and Use Committee, 10 New Zealand white rabbits were anesthetized (1% halothane in air) and mechanical ventilation was adjusted to maintain the arterial carbon dioxide tension at 35 mmHg (alpha-stat). A sensor to measure PO2 brain, PCO2 brain, pHbrain, and Tbrain was inserted into the brain through a burr hole in the skull. Tbrain was adjusted to 38 degrees C, 34.4 degrees C, and 29.4 degrees C in a random sequence in each animal. PO2 brain, PCO2brain, and pHbrain (all variables are reported at the actual Tbrain) were recorded every 10 s during a 5-min baseline, 3 min of cerebral ischemia induced by inflation of a neck tourniquet, and 10 min of reperfusion at each level of Tbrain. Analysis of variance and Dunnett's test were used for statistical analysis. Data are presented as means +/- SD.

Results

During ischemia, PO2 brain decreased from 56 +/- 3 to 33 +/- 2 mmHg at 38 degrees C, from 58 +/- 3 to 32 +/- 3 mmHg at 34.4 degrees C, and from 51 +/- 2 to 32 +/- 2 mmHg at 29.4 degrees C (p = NS). PCO2 brain increased by 6.7 +/- 2 mmHg at 38 degrees C, by 5.1 +/- 1.4 mmHg at 34.4 degrees C, and by 2.3 +/- 0.8 mmHg at 29.4 degrees C. pHbrain inversely followed the trend of PCO2 brain.

Conclusions

The attenuated increase in PCO2 brain during hypothermic ischemia results from the reduced CMRO2. The similar decrease in PO2 brain at all temperature levels indicates that despite the reduction in CMRO2, PO2 brain is no better preserved during brief episodes of hypothermic ischemia than during normothermic ischemia.

DESPITE the intensive study of a multitude of putative neuroprotective agents, [1–4]no drug has equaled the potent neuroprotective properties of hypothermia. As a consequence, systemic hypothermia is commonly used during cerebral aneurysm surgery and during open heart surgery, when there is a risk for embolization. [5–7]Recently, hypothermia was shown to be of benefit in patients with intracranial hypertension after head trauma. [8] 

Various mechanisms have been proposed to explain how hypothermia prevents or attenuates neurologic injury. The most obvious and oldest theory about these mechanisms is that the cerebral metabolic rate for oxygen (CMRO2) decreases with hypothermia, resulting in prolonged maintenance of aerobic metabolism. Recent studies, however, have shown that during mild hypothermia the neuroprotective effects far exceed the amount that would be predicted from the decrease in CMRO2. [9]It has also been shown that hypothermia substantially attenuates the release of neurotoxic excitatory amino acids during ischemia. [10]These substances are thought to play an important role in ischemia-induced neuronal death. [11] 

The concept that hypothermia protects by preserving cellular energy stores and aerobic metabolism is based on the observation that CMRO2is an inverse exponential function of temperature [12,13]: Q10= CMRO2a/(CMRO2b)10(Ta- Tb), where Q10is the temperature coefficient (Q10= 2.2 between 37 [degree sign] Celsius and 27 [degree sign] Celsius), [12,13]Taand Tbare two different temperature levels, and CMRO2a and CMRO2b are the values of CMRO2at Taand Tb, respectively. If we assume the value of CMRO2at 38 [degree sign] Celsius to be 100%, a 25% decrease in CMRO2at 34.4 [degree sign] Celsius and a 50% decrease in CMRO2at 29.4 [degree sign] Celsius therefore can be predicted.

The measurement of cerebral tissue oxygen tension (PO2brain) may provide insights into the influence of a decrease in CMRO2on the cellular oxygen supply under baseline conditions and during ischemia. With the development of continuous, in vivo (intravascular) monitoring techniques of arterial oxygen tension (PaO2), carbon dioxide tension (PaCO2), pH, and temperature, very small sensors with acceptable accuracy and precision are now available. [14]The small size of these sensors has led to growing interest in their use as monitors of brain tissue perfusion and oxygenation. [15,16]Indeed, it has been shown that changes in cerebral tissue oxygenation or perfusion due to hypocapnia, hypoxemia, or ischemia can be detected reliably with these devices. [15,16] 

The aim of the present study was to elucidate the effects of a decrease in CMRO2induced by a decrease in cerebral tissue temperature (Tbrain) on the cerebral tissue oxygen tension (PO2brain) during short episodes of global cerebral ischemia.

Laboratory Animals

After we received approval from the Animal Care and Use Committee, we studied 10 male New Zealand white rabbits. The rabbits were 2–3 months old and weighed 3.9 +/- 0.5 kg (mean +/- SD). The animals were fasted for 24 h before the start of the experiment and housed one per cage at the institutional Animal Resource Center, where they received routine veterinary care.

Anesthesia, Surgery, and Induction of Global Cerebral Ischemia

The animals were anesthetized in a plastic box by insufflation of 5% halothane in oxygen into the box. Then endotracheal intubation was performed using a tube with a 3-mm inner diameter and the animals were mechanically ventilated with 1% halothane in air, a tidal volume of 40–60 ml, and a respiratory rate of 12–18/min, adjusted to maintain the arterial carbon dioxide tension (PaCO2) at 35 mmHg using an alpha-stat regimen. A catheter was inserted into an ear vein and 0.9% saline was administered at a rate of 5–10 ml [center dot] kg sup -1 [center dot] h sup -1. An additional fluid bolus (40–60 ml) was given if mean arterial pressure decreased to < 55 mmHg. The rabbit's head was secured in a stereotactic frame, with the interaural line approximately 12 cm above the midchest. After infiltration with bupivacaine, the groin was incised and arterial and central venous cannulas were inserted into the femoral artery and vein. Mean arterial pressure was continuously recorded and arterial blood samples were obtained to measure PaO2, PaCO2, and arterial pH (1306 pH/Blood Gas Analyzer; Instrumentation Laboratory, Lexington, MA). Arterial oxygen tension, PaCO2, and arterial pH are reported at actual body temperature. The scalp was infiltrated with bupivacaine 0.25%, incised in the midline, and reflected laterally to expose the skull. A 2-mm burr hole was drilled 4 mm posterior and 4 mm lateral to the bregma, and after perforation of the dura with microscissors, a sensor (Paratrend 7; Biomedical Sensors, High Wycombe, Buckinghamshire, UK) to measure PO2brain, the cerebral tissue carbon dioxide tension (PCO2brain), cerebral tissue pH (pHbrain), and Tbrainwas inserted using a 20-gauge arterial cannula and a stereotactic manipulator. The arterial cannula served as an introducer sheath for the sensor and was fixed with its tip at the brain surface. The sensor (0.5-mm diameter) was inserted into the brain to a depth of 4 cm. The burr hole around the arterial cannula was sealed with bone wax. Two optical fibers (to measure PCO2brain and pHbrain), a miniaturized Clark electrode (for PO2brain), and a thermocouple (for Tbrain) were located near the tip of the catheter, which was covered with a gas- and ion-permeable microporous polyethylene membrane. The void between the components of the sensor was filled with acrylamide gel containing phenol red. Changes in the hydrogen ion concentration resulted in color changes of phenol red, which was detected by the pH fiberoptic element. The carbon dioxide sensor was also equipped with a barrier that is selectively permeable to carbon dioxide. The distances of the sensors from the tip of the catheter are pH: 6 mm; PCO2, 8 mm; PO2, 19 mm; and thermocouple, 17 mm. The positions of the electrodes in the brain were examined in three animals by inserting a catheter coated with Evan's blue dye and then dissecting the brains of those animals after they had been killed to locate the catheter track. The pH electrode and the PCO2electrode were positioned in the basal forebrain with the thermocouple and the PO2electrode in the hippocampus and in the parieto-occipital cortex, respectively. The time constant of the Paratrend 7 to respond to 90% of a signal change is <180 s. This time constant is independent of temperature over the range used in this study. The sensors were calibrated before an experiment according to the manufacturer's instructions using a calibration chamber, calibration gases, and tonometer.

An inflatable neck tourniquet was loosely secured around the rabbit's neck, and the frontoparietal electroencephalogram (EEG) was recorded using needle electrodes and a differential amplifier (model DP-304; Warner Instruments, Hamden, CT). To induce cerebral ischemia, mean arterial pressure was reduced to 30–40 mmHg with a 10–20 mg bolus of trimethaphan given intravenously. The neck tourniquet was then inflated to a pressure of 700 mmHg within 0.5 s using a regulated tank source of compressed air. The time interval between induction of ischemia and the onset of EEG isoelectricity was measured, as was the time from reperfusion to reappearance of the EEG. Three episodes of cerebral ischemia were produced in each animal, each lasting 3 min. To terminate ischemia, the neck tourniquet was deflated, and mean arterial pressure was restored to 80–100 mmHg with a 10–20 micro gram bolus of phenylephrine given intravenously. Every 10 s the values of PO2brain, PCO2brain, and pHbrainwere recorded during a 5-min baseline period, during 3 min of ischemia, and during 10 min of reperfusion. Cerebral tissue oxygen tension, PCO2brain, and pHbrainare reported at actual brain temperature.

After the third ischemic episode and collection of all data, the halothane concentration was increased to 5%, and the animals were killed with potassium chloride, 10 mmol given intravenously.

Manipulation of T sub brain

Tbrainwas adjusted to one of three levels (38 [degree sign] Celsius, 34.4 [degree sign] Celsius, or 29.4 [degree sign] Celsius) for each ischemic episode. Data collection was started as soon as Tbrainstabilized at the target value. The time intervals between the insertion of the probe and the first ischemia, as well as between the ischemic challenges was 2–3 h. Because we studied three different temperature levels in each animal, six sequences of temperatures were possible (for example, in animal 1, the sequence was 29.4 [degree sign] Celsius, 38 [degree sign] Celsius and 34.4 [degree sign] Celsius; in animal 2, the sequence was 38 [degree sign] Celsius, 34.4 [degree sign] Celsius, and 29.4 [degree sign] Celsius). The sequence of temperature levels was randomized. This procedure eliminated the possible bias originating from differences in the physiologic responses to repeated episodes of cerebral ischemia. Cooling was achieved by wrapping the animal in ice packs. Rewarming was performed using a servocontrolled infrared heat lamp and a heating pad.

Statistical Analysis

To facilitate statistical analysis, the 30 values recorded for each animal during the 5-min baseline period were averaged to yield a single number for PO2brain, PCO2brain, and pHbrain. Similarly, the 60 values recorded for each animal during the 10-min reperfusion period were averaged. The ischemic value was designated as the lowest (for PO2brain and pHbrain) or the highest (PCO2brain) value observed during the ischemic period. Analysis of variance was used to compare these averaged values of PO2brain, PCO2brain, and pHbrainat the three different levels of Tbrain. Repeated-measures analysis of variance was used to compare baseline values with ischemic and reperfusion values of PO2brain, PCO2brain, and pHbrain. The change from baseline in these variables during ischemia at 34.4 [degree sign] Celsius and 29.4 [degree sign] Celsius were compared with the changes that occurred at 38 [degree sign] Celsius using factorial analysis of variance and Dunnett's test. Differences in mean arterial pressure, PaO2, PaCO2, and arterial pH at the three levels of Tbrainwere tested for significance using factorial analysis of variance and Dunnett's test. Data are presented as means +/- SD.

Three episodes of ischemia were induced in each of the 10 animals. One animal died after induction of ischemia at 38 [degree sign] Celsius. Therefore, data from 9 episodes of ischemia at 38 [degree sign] Celsius, 10 episodes at 34.4 [degree sign] Celsius, and 10 episodes at 29.4 [degree sign] Celsius were analyzed.

T sub brain, Physiologic Data, and Electroencephalogram

At all three target temperature levels, Tbrain, mean arterial pressure, PaO2, PaCO2, and arterial pH remained stable during the experiment (Table 1). After induction of cerebral ischemia, the time to EEG isoelectricity was almost twice as long at 29.4 [degree sign] Celsius as at 38 [degree sign] Celsius (30 +/- 8 s vs. 18 +/- 6 s; P < 0.01). At 34.4 [degree sign] Celsius, EEG isoelectricity occurred after 21 +/- 8 s (P = NS compared with 38 [degree sign] Celsius). Electroencephalographic spikes were observed during reperfusion after 100 +/- 67 s at 38 [degree sign] Celsius, 99 +/- 54 s at 34.4 [degree sign] Celsius, and 77 +/- 20 s at 29.4 [degree sign] Celsius (P = NS).

PO sub 2 brain, PCO sub 2 brain, and pH sub brain

(Figure 1, Figure 2, Figure 3) show the course of PO sub 2 brain, PCO2brain, and pHbrainduring baseline, ischemia, and reperfusion. After induction of cerebral ischemia, P2brain rapidly decreased at all levels of Tbrain. The maximum decreases from the mean baseline values were 41 +/- 9% at 38 [degree sign] Celsius, 46 +/- 7% at 34.4 [degree sign] Celsius, and 38 +/- 8% at 29.4 [degree sign] Celsius. During reperfusion, PO2brain increased within 2 min, reaching maximum values 4–5 min after the start of reperfusion. Thereafter, PO2brain gradually decreased to baseline values. There were no differences in the trends of PO2brain during the baseline data recording period, during the ischemic episode, or during the reperfusion period. The decrease in PO2brain from the mean baseline value to the minimum value observed during ischemia was not significantly different among the three levels of Tbrain. PCO sub 2 brain remained stable during baseline, increased slightly during ischemia, increased further during the first 1.5 min of reperfusion, and then returned to baseline. As expected, PCO2brain was significantly lower at 34.4 [degree sign] Celsius and 29.4 [degree sign] Celsius than at 38 [degree sign] Celsius because of the alpha-stat ventilatory management. The maximum relative increase in PCO2brain after ischemia compared with the mean baseline values was 13 +/- 10% at 38 [degree sign] Celsius, 12 +/- 7% at 34.4 [degree sign] Celsius, and 7 +/- 6% at 29.4 [degree sign] Celsius. The time course of pHbrainshowed a stable baseline, a decrease during ischemia that lasted until 1.5 min of reperfusion, followed by an increase and finally stable values between 4.5 and 10 min of reperfusion.

The present study shows that a 3-min episode of global cerebral ischemia induces approximately a 40% decrease in PO2brain. Reduction of Tbrainto 34.4 [degree sign] Celsius or 29.4 [degree sign] Celsius has no effect on the minimum value of PO2brain during ischemia.

The absolute values of PO2brain during baseline, ischemia, and reperfusion in this study are similar to those previously reported. In normothermic cats anesthetized with halothane, a mean baseline PO2brain of 42 mmHg was observed that decreased to 25 mmHg during ischemia. [15]Halothane is reduced at the Clark electrode and may thereby cause a small increase in measured oxygen tension. [17,18]However, this effect is of minor importance for the interpretation of the results of this study because all animals continuously received halothane at the same concentration (1%).

Because the solubility of oxygen and carbon dioxide in blood or in extracellular fluid is an inverse function of temperature, the “capacity” of the fluid to contain gas molecules in solution increases at lower temperatures. [19]In this study, alpha-stat ventilatory management was chosen because it has been shown to better preserve cerebral autoregulation, is associated with a better neuropsychologic outcome after cardiopulmonary bypass procedures, and is more commonly used in clinical practice. [20,21]With alpha-stat management, PaCO2decreases during hypothermia if the PaCO2is reported at actual body temperature. By necessity, this alpha-stat management also resulted in lower values for PCO2brain when measured at 34.4 [degree sign] Celsius and 29.4 [degree sign] Celsius. Arterial oxygen tension and PO2brain are not affected because of the constant equilibration of pulmonary capillary blood with alveolar oxygen tension.

Despite a predicted decrease in CMRO2at a lower Tbrain, no differences in PO2brain were observed during ischemia. Tissue oxygen tension represents the balance between the rate of oxygen uptake by the cells (i.e., CMRO2) and the affinity of hemoglobin for oxygen. We might have predicted that PO2brain would be better preserved during ischemia if CMRO2was decreased. A higher PO2brain would therefore be expected after a 3-min episode of ischemia during hypothermia. However, PO2brain depends not only on CMRO2but also on the amount of oxygen released from the chemical binding to hemoglobin (i.e., oxyhemoglobin dissociation). The degree of oxyhemoglobin dissociation as a function of oxygen tension is described by the oxyhemoglobin dissociation curve. [22–24]A decrease in temperature causes a leftward shift of the oxyhemoglobin dissociation curve; that is, at a lower temperature a lower oxygen tension is required to achieve the same amount of capillary hemoglobin desaturation. [23]At least in part, this mechanism could have contributed to the fact that the absolute values in PO2brain and the decrease during ischemia were similar, independent of temperature. Other factors that influence the movement of oxygen from capillary blood into the interstitial space and cells are the diffusion properties for oxygen of the erythrocyte membranes and of the capillary walls, and the affinity of intramitochondrial cytochromes for oxygen. [25]Additional studies are needed to quantify these changes during hypothermia.

Although CMRO2was not directly measured in the present study, it is likely that it was substantially reduced at 34.4 [degree sign] Celsius and 29.4 [degree sign] Celsius compared with 38 [degree sign] Celsius. This assumption is supported by two independent observations that indicate a decrease in CMRO2. First, the increase in PCO2brain during ischemia was attenuated at lower temperatures. The increase in PCO2brain at 29.4 [degree sign] Celsius was almost exactly one half of that observed at 38 [degree sign] Celsius, whereas at 34.4 [degree sign] Celsius it fell between the values obtained at 29.4 [degree sign] Celsius and 38 [degree sign] Celsius. The second factor that may indirectly indicate a decrease in CMRO2at lower temperatures is the time until onset of EEG isoelectricity after induction of cerebral ischemia. The trigger mechanisms that cause a cessation of neuronal electrical activity during ischemia are not fully understood. The depletion of intracellular energy stores to a certain critical level that determines the borderline between energy required for neuronal function and for the maintenance of cellular integrity is likely to be associated with the termination of neuronal transmission during ischemia. [26]Indeed, it has been shown that the level of CMRO2before the onset of cerebral ischemia determines the latency of EEG isoelectricity during ischemia. [27]In the present study, the mean latencies to EEG isoelectricity at 29.4 [degree sign] Celsius and at 34.4 [degree sign] Celsius were 1.7 and 1.5 times longer than at 38 [degree sign] Celsius, respectively.

In conclusion, the induction of transient global cerebral ischemia caused a marked and reproducible decrease in PO2brain and pHbrainand an increase in PCO2brain. Despite the predicted decrease in CMRO2at 34.4 [degree sign] Celsius and 29.4 [degree sign] Celsius, no differences in PO2brain were observed during baseline, ischemia, or reperfusion compared with these parameters at 38 [degree sign] Celsius. Although the exact reasons for this observation cannot be sufficiently explained by the present data, the leftward shift of the oxyhemoglobin dissociation curve during hypothermia, a change in the diffusion properties of erythrocyte membranes and the capillary walls, and altered oxygen-cytochrome binding may have contributed to this observation. That PO2brain is not preserved by mild to moderate hypothermia during brief episodes of ischemia provides additional evidence that other mechanisms are important for hypothermic neuroprotection.

1.
Smith SE, Meldrum BS: Cerebroprotective effect of lamotrigine after focal ischemia in rats. Stroke 1995; 26:117-22.
2.
Wiard RP, Dickerson MC, Beek O, Norton R, Cooper BR: Neuro-protective properties of the novel antiepileptic lamotrigine in a gerbil model of global cerebral ischemia. Stroke 1995; 26:466-72.
3.
Simon RP, Swan JH, Griffiths T, Meldrum BS: Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain. Science 1984; 226:850-2.
4.
Ohkubo M, Kuno A, Katsuta K, Ueda Y, Shirakawa K, Nakanishi H, Nakanishi I, Kinoshita T, Takasugi H: Studies on cerebral protective agents. IX. Synthesis of novel 1,2,3,4-tetrahydroisoquinolines as N-methyl-D-aspartate antagonists. Chem Pharm Bull (Tokyo) 1996; 44:95-102.
5.
Murkin JM: The role of CPB management in neurobehavioral outcomes after cardiac surgery. Ann Thorac Surg 1995; 59:1308-11.
6.
Williams MD, Rainer WG, Fieger HG, Murray IP, Sanchez ML: Cardiopulmonary bypass, profound hypothermia, and circulatory arrest for neurosurgery. Ann Thorac Surg 1991; 52:1069-75.
7.
Hessmann M, Dossche K, Wellens F, Vanermen H, De Geest R: Surgical treatment of thoracic aneurysm: A 5-year experience. Cardiovasc Surg 1995; 3:19-25.
8.
Marion DW, Penrod LE, Kelsey SF, Obrist WD, Kochanek PM, Palmer AM, Wisniewski SR, DeKosky ST: Treatment of traumatic brain injury with moderate hypothermia. N Engl J Med 1997; 336:540-6.
9.
Busto R, Dietrich WD, Globus MY-T, Valdes I, Scheinberg P, Ginsberg MD: Small differences in intraischemic brain temperature critically determine the extent of ischemic neuronal injury. J Cereb Blood Flow Metab 1987; 7:729-38.
10.
Illievich UM, Zornow MH, Choi KT, Strnat MAP, Scheller MS: Effects of hypothermia or anesthetics on hippocampal glutamate and glycine concentrations after repeated transient global cerebral ischemia. Anesthesiology 1994; 80:177-86.
11.
Benveniste H, Jorgensen MB, Sandberg M, Christensen T, Hagberg H, Diemer NH: Ischemic damage in hippocampal CA1 is dependent on glutamate release and intact innervation from CA3. J Cereb Blood Flow Metab 1989; 9:629-39.
12.
Michenfelder JD, Theye RA: Hypothermia: Effect on canine brain and whole body metabolism. Anesthesiology 1968; 29:1107-12.
13.
Michenfelder JD, Milde JH: The relationship among canine brain temperature, metabolism, and function during hypothermia. Anesthesiology 1991; 75:130-6.
14.
Venkatesh B, Clutton Brock TH, Hendry SP: A multiparameter sensor for continuous intra-arterial blood gas monitoring: A prospective evaluation. Crit Care Med 1994; 22:588-94.
15.
Zauner A, Bullock R, Di X, Young HF: Brain oxygen, CO sub 2, pH, and temperature monitoring: Evaluation in the feline brain. Neurosurgery 1995; 37:1168-77.
16.
Hoffmann WE, Charbel FT, Edelman G: Brain tissue oxygen, carbon dioxide, and pH in neurosurgical patients at risk for ischemia. Anesth Analg 1996; 82:582-6.
17.
Bates ML, Feingold A, Gold MI: The effects of anesthetics on an in-vivo oxygen electrode. Am J Clin Pathol 1975; 64:448-51.
18.
Eberhard P, Fehlmann W, Mindt W: An electrochemical sensor for continuous intravascular oxygen monitoring. Biotelem Patient Monit 1979; 6:16-31.
19.
Hill DW: Physics Applied to Anaesthesia, fourth edition. London, Butterworth, 1980, pp 202-13.
20.
Patel RL, Turtle MR, Chambers DJ, James DN, Newman S, Venn GE: Alpha-stat acid-base regulation during cardiopulmonary bypass improves neuropsychologic outcome in patients undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 1996; 111:1267-79.
21.
Goldsack C, Berridge JC: Acid-base management during cardiopulmonary bypass. Current trends in the United Kingdom. Anaesthesia 1996; 51:396-8.
22.
Nunn JF: Applied Respiratory Physiology (third edition). London, Butterworth, 1987, pp 235-83.
23.
Astrup P, Engel K, Severinghaus JW, Munson E: The influence of temperature and pH on the dissociation curve of oxyhemoglobin of human blood. Scand J Clin Lab Invest 1965; 17:515-23.
24.
Kelman GR: Digital computer subroutine for the conversion of oxygen tension into saturation. J Appl Physiol 1966; 21:1375-6.
25.
Clark A Jr, Federspiel WJ, Clark PA, Cokelet GR: Oxygen delivery from red cells. Biophys J 1985; 47:171-81.
26.
Freund TF, Buzsaki G, Prohaska OJ, Leon A, Somogyi P: Simultaneous recording of local electrical activity, partial oxygen tension and temperature in the rat hippocampus with a chamber-type micro-electrode. Effects of anaesthesia, ischemia and epilepsy. Neurosci 1989; 28:539-49.
27.
Astrup J, Rehncrona S, Siesjo BK: The increase in extracellular potassium concentration in the ischemic brain in relation to the preischemic functional activity and cerebral metabolic rate. Brain Res 1980; 199:161-74.